Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Preliminary report
The results of the threshold analysis revealed that, under the base-case assumptions, GLP-1 RAs would be cost-effective at an annual cost of AU$450 in the total population and AU$500 in the secondary prevention population
However, phase II clinical trials were conducted to investigate ipamorelin for post-operative ileus treatment but the trials were discontinued due to its limited efficacy
Refer to Aetna.com for more information about Aetna plans
How widespread is GLP-1 usage in the U.S
This is why having a reliable relief protocol matters regardless of where you are in your treatment timeline
US$ 24.32
US$ 22.09
US$ 21.45
US$ 26.32
US$ 24.50
